22-45518715-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006486.3(FBLN1):c.113C>T(p.Ala38Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000695 in 1,611,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006486.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBLN1 | NM_006486.3 | c.113C>T | p.Ala38Val | missense_variant | 2/17 | ENST00000327858.11 | |
FBLN1 | NM_001996.4 | c.113C>T | p.Ala38Val | missense_variant | 2/15 | ||
FBLN1 | NM_006485.4 | c.113C>T | p.Ala38Val | missense_variant | 2/15 | ||
FBLN1 | NM_006487.3 | c.113C>T | p.Ala38Val | missense_variant | 2/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBLN1 | ENST00000327858.11 | c.113C>T | p.Ala38Val | missense_variant | 2/17 | 1 | NM_006486.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000106 AC: 26AN: 244352Hom.: 0 AF XY: 0.000129 AC XY: 17AN XY: 132278
GnomAD4 exome AF: 0.0000665 AC: 97AN: 1458852Hom.: 0 Cov.: 32 AF XY: 0.0000855 AC XY: 62AN XY: 725368
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 21, 2023 | The c.113C>T (p.A38V) alteration is located in exon 2 (coding exon 2) of the FBLN1 gene. This alteration results from a C to T substitution at nucleotide position 113, causing the alanine (A) at amino acid position 38 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at